Verastem (VSTM) Total Liabilities (2011 - 2026)
Verastem's (VSTM) quarterly Total Liabilities came in at $146.0 million in Q1 2026, down 11.03% year-on-year from $164.1 million in Q1 2025, and down 22.83% quarter-over-quarter from $189.2 million in Q4 2025.
Verastem (VSTM) Total Liabilities (2011 - 2026) Analysis & Trends
Verastem's Total Liabilities history runs 16 years deep, the most recent figure standing at $146.0 million for Q1 2026.
- On a quarterly basis, Total Liabilities fell 11.03% year-over-year to $146.0 million in Q1 2026; TTM through Mar 2026 was $146.0 million, a 11.03% decrease from a year earlier, with the FY2025 full-year figure at $189.2 million, up 45.09% from the prior year.
- Total Liabilities declined to $146.0 million in Q1 2026 per VSTM's latest filing, from $189.2 million in the prior quarter.
- Across five years, Total Liabilities topped out at $192.4 million in Q3 2025 and bottomed at $43.4 million in Q1 2022.
- The 5-year median for Total Liabilities is $71.8 million (2023), against an average of $99.1 million.
- Across the five-year window, Total Liabilities soared 197.26% in 2022 and dropped 11.03% in 2026, its largest moves.
- Year by year, Total Liabilities stood at $47.7 million in 2022, then soared by 49.36% to $71.2 million in 2023, then soared by 83.23% to $130.4 million in 2024, then surged by 45.09% to $189.2 million in 2025, then declined by 22.83% to $146.0 million in 2026.
- Per Business Quant, the three latest VSTM Total Liabilities figures stand at $146.0 million (Q1 2026), $189.2 million (Q4 2025), and $192.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 60.46 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 177.22 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 3.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 7.33 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 7.12 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 9.45 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 15.48 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.62 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 753.82 Mn |
| 10 | Verastem | 166.09 Mn | -31.73 Mn | 15.90 Mn | 146.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 146.03 Mn |
| Dec 31, 2025 | 189.25 Mn |
| Sep 30, 2025 | 192.38 Mn |
| Jun 30, 2025 | 160.21 Mn |
| Mar 31, 2025 | 164.13 Mn |
| Dec 31, 2024 | 130.43 Mn |
| Sep 30, 2024 | 94.16 Mn |
| Jun 30, 2024 | 65.74 Mn |
| Mar 31, 2024 | 77.32 Mn |
| Dec 31, 2023 | 71.19 Mn |
| Sep 30, 2023 | 71.81 Mn |
| Jun 30, 2023 | 69.01 Mn |
| Mar 31, 2023 | 66.69 Mn |
| Dec 31, 2022 | 47.66 Mn |
| Sep 30, 2022 | 48.22 Mn |
| Jun 30, 2022 | 46.52 Mn |
| Mar 31, 2022 | 43.38 Mn |
| Dec 31, 2021 | 21.10 Mn |
| Sep 30, 2021 | 16.22 Mn |
| Jun 30, 2021 | 35.69 Mn |